Neurogene (NGNE) Research & Development (2013 - 2026)
Neurogene (NGNE) posted Research & Development of $25.47 million for Q2 2026, up 31.5% from $19.37 million a year earlier and up 1.3% from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Research & Development (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Neurogene was $88.5 million, up 28.7% year-over-year; for FY2025, it was $75.01 million, up 23.1% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 25.2% (FY2020 to FY2025).
- In prior years, Neurogene's Research & Development was $60.92 million in FY2024 (+37.2%), $44.39 million in FY2023 (-6.5%), $47.51 million in FY2022 (+21.3%) and $39.16 million in FY2021 (+60.9%).
- The Q2 2026 figure stands as the highest quarterly Research & Development in data going back to Q1 2013.
- On a year-over-year basis, Research & Development has increased in each of the last ten quarters, with growth averaging 29.2% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2022, with growth of 67.8%; the weakest was Q4 2023, with a decline of 25.6%.
- According to Business Quant data, Research & Development for the three prior quarters was $25.15 million (Q1 2026), $20.64 million (Q4 2025) and $17.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Neurogene | 642.28 Mn | 642.28 Mn | - | 25.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.47 Mn |
| Mar 31, 2026 | 25.15 Mn |
| Dec 31, 2025 | 20.64 Mn |
| Sep 30, 2025 | 17.24 Mn |
| Jun 30, 2025 | 19.37 Mn |
| Mar 31, 2025 | 17.76 Mn |
| Dec 31, 2024 | 15.35 Mn |
| Sep 30, 2024 | 16.29 Mn |
| Jun 30, 2024 | 15.74 Mn |
| Mar 31, 2024 | 13.54 Mn |
| Dec 31, 2023 | 12.18 Mn |
| Sep 30, 2023 | 11.61 Mn |
| Jun 30, 2023 | 10.32 Mn |
| Mar 31, 2023 | 10.28 Mn |
| Dec 31, 2022 | 16.38 Mn |
| Sep 30, 2022 | 9.47 Mn |
| Jun 30, 2022 | 10.96 Mn |
| Mar 31, 2022 | 10.70 Mn |
| Dec 31, 2021 | 9.76 Mn |
| Sep 30, 2021 | 9.90 Mn |
API Access
Neurogene Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();